GENE ONLINE|News &
Opinion
Blog

Sanofi
Billion-Dollar AI Deals Powering Antibody Design, Biologics, and Next-Gen Therapies
2024-09-25
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
GeneOnline’s Pick: Top 10 Global Industry News Stories in 2023 (Part 1)
2024-01-08
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
Sanofi Inks Two Major Strategic R&D Collaborations in a Single Week
2023-07-24
GeneOnline’s Weekly News Highlights: July 17-21
2023-07-24
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Sanofi Goes “All In” to Lead the AI Revolution in Pharmaceutical Industry
2023-06-18
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
Sobi Enters Into New Royalty Agreement on RSV Antibody Drug Nirsevimab With Sanofi
2023-04-11
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
FDA Approves Sanofi and Sobi’s Once-Weekly Hemophilia A Med
2023-02-23
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
Insilico Makes its Biggest AI Deal Ever with Sanofi for Potential $1.2 Billion
2022-11-09
1 2 3 5
LATEST
Big Pharma’s Next Move: BMS, Merck, Amgen Eye M&A to Tackle Patent Expirations
2024-11-14
Taiwan and Australia Bridge Biotech Frontiers and Strengthen Ties at AusBiotech 2024
2024-11-14
Google DeepMind Open-Sources AlphaFold 3: A Game-Changer for Drug Discovery and Biotech
2024-11-12
Hiroaki Ueno: Leading Japan’s Pharma Revolution with Innovation and Global Strategy
2024-11-12
Japan’s Bio-Economy Push: A Future Driven by Innovation and Global Collaboration
2024-11-12
Opening the Door to ‘Designer Babies’? South Africa’s Genome Editing Guidelines Spark Global Debate
2024-11-08
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
2024-11-08
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top